Ted Warkentin

Dr. Theodore (Ted) E. Warkentin, MD, BSc(Med), FRCP(C), FACP, is a clinical and laboratory hematologist and transfusion medicine director at Hamilton General Hospital, and is a Professor in the Department of Pathology and Molecular Medicine, and the Department of Medicine, at McMaster University, in Hamilton, Ontario, Canada. His clinical work and related research focuses on acquired thrombocytopenias and coagulopathies—most notably the topics of “heparin-induced thrombocytopenia (HIT)” and "ischemic limb gangrene with pulses" (symmetrical peripheral gangrene/purpura fulminans associated with critical illness). Dr. Warkentin devised the “4Ts”, a widely-used scoring system for evaluating clinical probability of HIT. He is a co-winner (with Prof. John Kelton) of the 2015 Prix Galien Canada Prize, the highest award for Canadian scientists who have made significant advances in pharmaceutical research. He also identified “spontaneous HIT syndrome” (a rare HIT-mimicking disorder that occurs despite absence of preceding heparin exposure), and other examples of “autoimmune HIT”—a group of unusual clotting disorders that provides insight into “vaccine-induced immune thrombotic thrombocytopenia (VITT),” a novel prothrombotic anti-PF4 platelet-activating disorder that rarely is caused by adenoviral vector vaccines. He has co-edited (with Prof. Greinacher) 5 editions of a book, Heparin-Induced Thrombocytopenia, has authored 107 book chapters and 400 peer-reviewed articles, and has given over 890 lectures to national and international audiences.

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.